PBMT Associated With a Pulmonary Rehabilitation Program on the Functional Capacity of Patients With COPD
NCT07878884
Summary
This study aims to evaluate the effectiveness of photobiomodulation therapy (PBMT) as an adjunct to the pulmonary rehabilitation program on the functional capacity of patients with COPD. This is a randomized, placebo-controlled, double-blind clinical trial conducted with 20 patients from the outpatient clinic of the Integrated Cardiopulmonary and Metabolic Rehabilitation Service of Santa Casa de Porto Alegre. Patients will be allocated to the active PBMT group, receiving photobiomodulation treatment prior to the exercise protocol of the pulmonary rehabilitation program, in the respiratory and peripheral muscles, or the placebo group, which will receive the therapy application at the same points but without the therapeutic dose, prior to rehabilitation. Sixteen PBMT applications will be performed over eight weeks, with a frequency of twice a week. The exercises performed in the institution's pulmonary rehabilitation program by the patients will not be interfered with by the researchers. Evaluations will be carried out in three stages: immediately after recruitment, after 8 interventions, and after 16 interventions.
Eligibility
Inclusion Criteria: * Patients diagnosed with COPD, in the maintenance phase, with GOLD classification 3 and 4; * Ability to walk. Exclusion Criteria: * Cognitive dysfunction that prevents the completion of assessments, as well as inability to understand and sign the informed consent form (ICF); * Patients with sequelae of stroke; * Recent acute myocardial infarction (within two months); * Uncontrolled hypertension; * Heart failure grade IV according to the New York Heart Association or decompensated; * Unstable angina or arrhythmia; * Peripheral vascular alterations in lower limbs such as deep vein thrombosis; * Disabling osteoarticular or musculoskeletal disease; * Patients with cancer and/or undergoing cancer treatment; * Patients with systemic lupus erythematosus; * Pacemaker or cardiac defibrillator; * Hemophilia; * Recent skin lesions or tattoos at the site of therapy application.
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07878884